Back
Envista Holdings Vs. Spyre Therapeutics Industry Stock Comparison
Sell
37
NVST
Envista Holdings
Last Price:
19.77
Seasonality Move:
7.83%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Sell
37
Envista Holdings (NVST)
is a Sell
Is Envista Holdings a Buy, Sell or Hold?
- The current Envista Holdings [NVST] share price is $19.25. The Score for NVST is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- NVST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVST Stock Price Chart
What is Envista Holdings's stock price today?
-
The Envista Holdings share price today is $19.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVST is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
NVST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 59.58 | Buy |
| Chaikin Money Flow: | 990280 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.71 - 19.11) | Buy |
| Bollinger Bands (100): | (16.54 - 18.74) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 53.02 | Buy |
| Chaikin Money Flow: | 71063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.98 - 29.52) | Buy |
| Bollinger Bands (100): | (25.44 - 33.84) | Sell |
NVST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.04 | Buy |
| 20-day SMA: | 18.41 | Buy |
| 50-day SMA: | 17.57 | Buy |
| 200-day SMA: | 19.91 | Sell |
| 8-day EMA: | 18.92 | Buy |
| 20-day EMA: | 18.54 | Buy |
| 50-day EMA: | 18.02 | Buy |
| 200-day EMA: | 20.31 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.1 | Sell |
| 20-day SMA: | 28.66 | Buy |
| 50-day SMA: | 27.88 | Buy |
| 200-day SMA: | 29.31 | Sell |
| 8-day EMA: | 28.88 | Buy |
| 20-day EMA: | 28.56 | Buy |
| 50-day EMA: | 28.37 | Buy |
| 200-day EMA: | 27.36 | Buy |
Envista Holdings Earnings Growth & NVST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.89 per share, and an increase next year of $0.41 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Envista Holdings Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||